Found 14 matching trials
Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors PHASE1 The subject of this study is the adoptive transfer of selected autologous t...
Show More Status
Active Not Recruiting
Location
Providence Portland Medical Center
Learn More & Join Trial
Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease PHASE1 This research study aims to evaluate the safety and effectiveness of a nove...
Show More Location
AHN West Penn Hospital
Learn More & Join Trial
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab PHASE2 Background:
Cell therapy is an experimental cancer therapy. It takes young...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL) PHASE2 Background:
The presence of T-lymphocytes in resected tumor samples derive...
Show More Location
Vall d'Hebron Institute of Oncology
Learn More & Join Trial
Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma PHASE2 The purpose of this study is to find out more about the effects of an inves...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
TIL-ACT After NMA Chemo with IL-2 and Nivo Rescue in Metastatic Melanoma (mMEL) PHASE1 This is a single center, single arm phase I trial to test the feasibility a...
Show More Location
CHUV Oncology Department
Learn More & Join Trial
Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts NA Purpose of this Pilot Study: The investigators want to study the safety, si...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung Cancer PHASE2 This study is a Phase 2, open-label, multicenter study evaluating adoptive ...
Show More Location
University of California San Diego, Moores Cancer Center
Learn More & Join Trial
Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC PHASE1 The purpose of the study is to evaluate the feasibility, safety and tolerab...
Show More Status
Active Not Recruiting
Location
Moffitt Cancer Center
Learn More & Join Trial
Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases PHASE1 Evaluate the safety and tolerability of treatment with autologous tumor inf...
Show More Location
Multiple Locations
Learn More & Join Trial